Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Hepatitis

Free Subscription 01.07.2024 1 AIDS 1 Am J Gastroenterol 1 Dig Dis Sci 1 Gastroenterol Hepatol 2 Hepatology 5 J Hepatol 1 J Infect Dis 2 J Med Virol 1 Pediatr Infect Dis J 1 PLoS Med 5 PLoS One 1 Virology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. MATHUR P, Ramadhani HO, Kaplan R, Stafford KA, et al
   Interferon-free hepatitis C treatment increases a surrogate of atherosclerotic cardiovascular disease risk in Black veterans living with HIV.
   AIDS. 2024;38:1437-1439.
   PubMed         Abstract available
   
   

   
   Am J Gastroenterol

2. HUANG SC, Su TH, Tseng TC, Liao SH, et al
   Pre-existing and new-onset metabolic dysfunctions increase cirrhosis and its complication risks in chronic hepatitis B.
   Am J Gastroenterol. 2024 Jun 26. doi: 10.14309/ajg.0000000000002915.
   PubMed         Abstract available
   
   

   
   Dig Dis Sci

3. LEY D, Lazarus S, Forati AM, Farraye FA, et al
   High Rates of Seroprotection to Hepatitis B After a Hepatitis B Challenge Dose in Previously Vaccinated Patients with Inflammatory Bowel Disease on Immunosuppressive Therapy.
   Dig Dis Sci. 2024 Jun 21. doi: 10.1007/s10620-024-08527.
   PubMed         Abstract available
   
   

   
   Gastroenterol Hepatol

4. RODRIGUEZ-TAJES S, Palom A, Giraldez Gallego A, Moreno A, et al
   Characterizing Hepatitis Delta in Spain and the gaps in its management.
   Gastroenterol Hepatol. 2024 Jun 20:502222. doi: 10.1016/j.gastrohep.2024.502222.
   PubMed         Abstract available
   
   

   
   Hepatology

5. LAW JL, Drummer HE
   Bridging the gap: A new tool to down select HCV vaccine candidates.
   Hepatology. 2024 Jun 27. doi: 10.1097/HEP.0000000000000948.
   PubMed        
   
   
6. LIAO X, Fan R
   Letter to the Editor: Chronic hepatitis B baseline viral load and on-treatment liver cancer risk: A multinational cohort study of HBeAg-positive patients.
   Hepatology. 2024 May 28. doi: 10.1097/HEP.0000000000000942.
   PubMed        
   
   

   
   J Hepatol

7. KUDARAVALLI S, Huang DQ, Yeh ML, Trinh L, et al
   Sex and ethnic disparities in hepatitis B evaluation and treatment across the world.
   J Hepatol. 2024;81:33-41.
   PubMed         Abstract available
   
   
8. RICCO G, Brunetto MR
   Reply to: "Increase in HDV replication during steroid therapy - potential implications for testing and treatment strategies".
   J Hepatol. 2024;81:e51-e53.
   PubMed        
   
   
9. GHANY MG, Buti M, Lampertico P, Lee HM, et al
   Reply to: "Ultrasensitive HBsAg testing predicts HBsAg seroreversion outcomes: Considerations for new and existing therapies".
   J Hepatol. 2024;81:e26-e27.
   PubMed        
   
   
10. ANDERSON M, Holzmayer V, Stec M, Cloherty G, et al
    Ultrasensitive HBsAg testing predicts HBsAg seroreversion outcomes: Considerations for new and existing therapies.
    J Hepatol. 2024;81:e24-e25.
    PubMed        
    
    
11. PATMORE LA, van der Eijk AA, Janssen HLA, de Man RA, et al
    Increase in HDV replication during steroid therapy - potential implications for testing and treatment strategies.
    J Hepatol. 2024;81:e49-e50.
    PubMed        
    
    

    
    J Infect Dis

12. BALAGOPAL A, Thio CL
    Hepatitis B surface antigen loss: what does integration have to do with a functional HBV cure?
    J Infect Dis. 2024 Jun 24:jiae327. doi: 10.1093.
    PubMed        
    
    

    
    J Med Virol

13. SHIN H, Lim GS, Yoon JW, Ko Y, et al
    Metabolic effects and cardiovascular disease risks of antiviral treatments in patients with chronic hepatitis B.
    J Med Virol. 2024;96:e29760.
    PubMed         Abstract available
    
    
14. GU F, Zeng K, Lan X, He Y, et al
    Measuring HBV pregenomic RNA may be a potential biomarker to determine HBV functional cure in HIV/HBV-co-infected patients with HBsAg loss.
    J Med Virol. 2024;96:e29762.
    PubMed         Abstract available
    
    

    
    Pediatr Infect Dis J

15. SOONTHORNARRAK K, Limrungsikul A, Apiwattanakul N
    Comparison of Hepatitis B Surface Antibody Levels After Vaccination With Combined One Dose of Hexavalent Vaccine and Two Doses of Pentavalent Vaccine Versus Three Doses of Pentavalent Vaccine.
    Pediatr Infect Dis J. 2024 Jun 24. doi: 10.1097/INF.0000000000004449.
    PubMed         Abstract available
    
    

    
    PLoS Med

16. LIM AG, Scott N, Walker JG, Hamid S, et al
    Correction: Health and economic benefits of achieving hepatitis C virus elimination in Pakistan: A modelling study and economic analysis.
    PLoS Med. 2024;21:e1004423.
    PubMed         Abstract available
    
    

    
    PLoS One

17. GURAV YK, Bagepally BS, Chitpim N, Sobhonslidsuk A, et al
    Cost-effective analysis of hepatitis A vaccination in Kerala state, India.
    PLoS One. 2024;19:e0306293.
    PubMed         Abstract available
    
    
18. FARHAN M, Shah Z, Ling Z, Shah K, et al
    Global dynamics and computational modeling for analyzing and controlling Hepatitis B: A novel epidemic approach.
    PLoS One. 2024;19:e0304375.
    PubMed         Abstract available
    
    
19. NAM DE, Park SJ, Omole S, Um E, et al
    Activated Gab1 drives hepatocyte proliferation and anti-apoptosis in liver fibrosis via potential involvement of the HGF/c-Met signaling axis.
    PLoS One. 2024;19:e0306345.
    PubMed         Abstract available
    
    
20. SALIA E, Nartey YA, Djankpa FT, Pappoe F, et al
    Prevalence of occult hepatitis B infection among treatment-naive persons living with HIV in Ghana.
    PLoS One. 2024;19:e0305862.
    PubMed         Abstract available
    
    
21. ZEZIULIN O, Kornilova M, Deac A, Morozova O, et al
    Modes of HIV transmission among young women and their sexual partners in Ukraine.
    PLoS One. 2024;19:e0305072.
    PubMed         Abstract available
    
    

    
    Virology

22. CHEN Y, Xu S, Tang Y, Zhang C, et al
    Pathogenicity of two different genotypes avian hepatitis E strains in laying hens and silkie fowl.
    Virology. 2024;597:110154.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge.